Data / Form D filings / ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc.: Form D filings
ADARx Pharmaceuticals, Inc., a biotechnology company in San Diego, CA, filed 7 Form D notices with the SEC between 2020 and 2023. The latest, on August 10, 2023, reports $200 million sold of a $200 million offering to 28 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5871 Oberlin Drive, Suite 200, San Diego, CA, 92121
- Phone
- (858) 283-9472
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1802369
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | New notice | $200,000,012 | $200,000,012 | 28 | Aug 2, 2023 | sec.gov | |
| Jan 26, 2023 | New notice | $45,999,999 | $45,999,999 | 10 | Jan 26, 2023 | sec.gov | |
| Aug 17, 2021 | New notice | $74,999,996 | $74,999,996 | 6 | Jul 30, 2021 | sec.gov | |
| May 24, 2021 | New notice | $15,499,998 | $15,499,998 | 3 | May 14, 2021 | sec.gov | |
| Nov 17, 2020 | New notice | $6,000,000 | $6,000,000 | 3 | Nov 4, 2020 | sec.gov | |
| Aug 7, 2020 | New notice | $5,000,000 | $5,000,000 | 3 | Jul 24, 2020 | sec.gov | |
| Feb 6, 2020 | New notice | $5,000,000 | $5,000,000 | 3 | Jan 24, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rui Zhu | Executive Officer | |
| Simeon George | Director | |
| Judith Li | Director | |
| Erez Chimovits | Director | |
| Sheila Gujrathi | Director | |
| Zhen Li | Executive Officer, Director, Promoter | |
| Yuan (Eliza) Sun | Director | |
| Chen Yu | Director | |
| Ricky Sun | Director | |
| Lorence Kim | Director | |
| Carl Gordon | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 7, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ADARx Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.